Head of Early Asset, OBU, International

Introduction to role:

Are you ready to turn breakthrough science into high impact launches across diverse markets accelerating access for patients who need new options most This role sits at the critical junction between discovery and delivery converting mechanism of action biomarkers and clinical profiles into clear value-maximizing pathways that work in the real world.

You will lead how our earliest oncology assets progress from Phase 2 decisions through registration and launch shaping evidence access and diagnostic strategies that reflect local standards of care and payer a setting that empowers local ownership you will bring entrepreneurial thinking to complex fast-moving environments so that each decision advances both patient outcomes and business performance.

Accountabilities:

• Asset Strategy Ownership : Set the International Oncology asset strategy from Phase 2 decision points through Phase 3 and COMMID translating mechanism...